secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rani Therapeutics Holdings, Inc. (RANI)
CIK:        0001856725
Form:       8-K
Filed at:   2025-10-27T23:59:59+00:00
Accession:  0001193125-25-250614
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Rani Therapeutics closes private placement of 42.6M shares and warrants; board changes
--------------------------------------------------------------------------------

- Closed private placement of 42,633,337 shares of Class A common stock, warrants to purchase 125,000,004 shares, and pre-funded warrants for 82,366,667 shares.
- Post-closing shares outstanding: 97,541,221.
- Directors Andrew Farquharson and Maulik Nanavaty resigned effective closing; no disagreement cited.
- Abraham Bassan (Samsara BioCapital) and Vasudev Bailey (Anomaly Ventures) appointed as directors.
- Samsara and Anomaly each have board designation rights while holding at least 25% of securities issued.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1856725/000119312525250614/0001193125-25-250614-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1856725/000119312525250614/d935516d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-250614

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer